About this trial
This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women who delivered at the Department of Obstetrics and Gynecology of Istanbul Training and Research Hospital between March 2025 and March 2027.
Age between 18 and 48 years.
Presence of a bleeding postpartum obstetric laceration (first- or second-degree) without an anatomical defect requiring surgical repair.
Absence of additional conditions that may affect the amount of postpartum bleeding, such as uterine atony or retained placental tissue.
Disqualifiers
Age younger than 18 years or older than 48 years.
Absence of a bleeding postpartum first- or second-degree obstetric laceration meeting the study criteria.
Presence of an obstetric laceration with an anatomical defect requiring surgical repair.
Presence of additional causes or conditions that may affect postpartum blood loss, such as uterine atony or retained placental tissue.
Trial design
Parallel
Treatments tested in this trial
Chitosan-covered-gauze application
Procedure/SurgeryEffectiveness of chitosan-covered-gauze in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears
Suturation
Procedure/SurgeryEffectiveness of suturation in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears
Treatment groups
Trial outcomes
Primary outcomes
Amount of bleeding
Total amount of blood which is calculated by subtracting the dry weight of surgical absorbant gauze materials from their soaked weight
Sponsors and contacts
Click on the lead sponsor to view all of their trials.